Axa’s Chimerix, Inc. CMRX Stock Holding History

Axa’s Portfolio CMRX Stock Details CMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-195,200	Closed	-$894K	–	1240
2022 Q1	$894K	Hold	195,200	–	–	﹤0.01%	968
2021 Q4	$1.25M	Sell	195,200 -11,500	-6%	-$69K	﹤0.01%	921
2021 Q3	$1.28M	Buy	206,700 +166,900	+419%	+$1.15M	﹤0.01%	939
2021 Q2	$318K	Hold	39,800	–	–	﹤0.01%	1166
2021 Q1	$384K	Buy	39,800 +14,900	+60%	+$137K	﹤0.01%	1105
2020 Q4	$120K	Buy	+24,900	New	+$90.3K	﹤0.01%	1194
2019 Q4	–	Sell	-206,300	Closed	-$485K	–	1346
2019 Q3	$485K	Hold	206,300	–	–	﹤0.01%	1100
2019 Q2	$891K	Sell	206,300 -58,073	-22%	-$179K	﹤0.01%	995
2019 Q1	$555K	Sell	264,373 -54,700	-17%	-$125K	﹤0.01%	1088
2018 Q4	$820K	Hold	319,073	–	–	﹤0.01%	998
2018 Q3	$1.24M	Hold	319,073	–	–	﹤0.01%	987
2018 Q2	$1.52M	Hold	319,073	–	–	0.01%	917
2018 Q1	$1.66M	Hold	319,073	–	–	0.01%	886
2017 Q4	$1.48M	Buy	319,073 +52,400	+20%	+$249K	0.01%	920
2017 Q3	$1.4M	Buy	266,673 +8,100	+3%	+$39.9K	0.01%	892
2017 Q2	$1.41M	Buy	258,573 +191,400	+285%	+$1.01M	0.01%	856
2017 Q1	$429K	Sell	67,173 -28,407	-30%	-$161K	﹤0.01%	1104
2016 Q4	$440K	Sell	95,580 -40,000	-30%	-$189K	﹤0.01%	1078
2016 Q3	$751K	Sell	135,580 -3,400	-2%	-$15.6K	﹤0.01%	940
2016 Q2	$546K	Buy	+138,980	New	+$687K	﹤0.01%	992
2016 Q1	–	Sell	-296,981	Closed	-$2.66M	–	1432
2015 Q4	$2.66M	Buy	296,981 +97,089	+49%	+$3.5M	0.01%	720
2015 Q3	$7.64M	Sell	199,892 -4,228	-2%	-$209K	0.03%	450
2015 Q2	$9.43M	Hold	204,120	–	–	0.04%	437
2015 Q1	$7.69M	Buy	204,120 +14,415	+8%	+$572K	0.03%	459
2014 Q4	$7.64M	Sell	189,705 -65,273	-26%	-$2.21M	0.03%	457
2014 Q3	$7.04M	Buy	254,978 +34,978	+16%	+$849K	0.03%	449
2014 Q2	$4.83M	Buy	220,000 +183,620	+505%	+$3.65M	0.02%	552
2014 Q1	$831K	Buy	+36,380	New	+$734K	﹤0.01%	964

Other funds holding CMRX

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Axa's CMRX Position: Q2 2022 in Review

Axa sold out of Chimerix, Inc. (CMRX) in Q2 2022, closing a stake of 195,200 shares — an estimated $894K sold.

Axa first reported a position in CMRX in Q1 2014 and held it in 28 quarters. The position peaked at $9.43M in Q2 2015. 117 funds tracked by Wall St. Rank hold CMRX as of Q2 2022.

Axa reported no remaining Chimerix, Inc. position as of Q2 2022 after selling out during the quarter.
Axa sold 195,200 Chimerix, Inc. shares in Q2 2022, an estimated $894K.
Axa first reported a position in Chimerix, Inc. in Q1 2014 and held it in 28 quarters.
Axa's Chimerix, Inc. position peaked at $9.43M in Q2 2015.
117 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q2 2022.

Based on Axa's 13F filing for Q2 2022, filed 15 Aug 2022.